Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1989-10-11
1990-12-04
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61U 3144
Patent
active
049754360
ABSTRACT:
The invention relates to the use of compounds which act as 5-hydroxytryptamine (5-HT) antagonists at 5-HT "M" receptors in the treatment of anxiety.
REFERENCES:
patent: 4695578 (1987-09-01), Coates et al.
patent: 4721720 (1988-01-01), Wootton et al.
patent: 4725603 (1988-02-01), Sanger et al.
patent: 4783478 (1988-11-01), Wootton et al.
patent: 4786643 (1988-11-01), Sanger et al.
patent: 4851407 (1989-07-01), Wootton et al.
patent: 4886808 (1989-12-01), King
Adv. Biochemical Psychoharmacology, 14, 29-44, 1975, Stein et al.
Iversen, "5-HT and Anxiety", Neuropharm, 1984, 23, 1553-1560.
Friedman Stanley J.
Glaxo Group Limited
LandOfFree
Treatment of anxiety does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of anxiety, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of anxiety will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-883603